Amir Meftah, MD, discusses the possibility of GLP-1s for addressing metabolic issues associated with antipsychotics.

Dana Hilt, MD, PhD, discusses data on Xanamem’s impact on cortisol and its potential use in MDD at the APA Annual Meeting.

What should you know about the lesser known psychedelics? Clinical insights from Jacob Perlson, MD, MPH, at the APA Annual Meeting.

Our board members are presenting at this year's APA Annual Meeting. Be sure to check out their sessions!

The Osheroff v. Chestnut Lodge case had a transformative impact on psychiatric practices and the evolving relationship between science and religion.

New analyses reveal valbenazine (Ingrezza) significantly enhances quality of life and functional outcomes for patients with tardive dyskinesia, supporting its long-term efficacy.

Psychiatrists can leverage media to reshape mental health narratives, combat misinformation, and engage with the public, in a way that fosters open conversations and reduces stigma.

"I feel I’ve known him a long time, familiar as red in the maple outside or the smell of leather on my father’s skin..."

Etkin describes precision psychiatry data for MDD presented at the Society for Biological Psychiatry Annual Meeting.

Mental health professionals should navigate media engagement by upholding ethical standards, ensuring informed consent, and combating misinformation to promote public awareness.

Uncertainty fuels anxiety, yet knowing outcomes—even grim ones—can bring relief.

Check out this year's Gerald F. Berlin Prize winner!

Let's take another look at the connection between motherhood and mental health.

Badr Ratnakaran, MBBS, Psychiatric Times' new Climate Change Section Editor, explores the intersection of climate change and mental health, highlighting the urgent need for awareness and support in clinical practice.

"And I feel closer to him than 50 minutes should allow, a puzzled sensation, I’ve known him all my life..."

Hypersomnias are a complex set of sleep disorders. Proper sleep evaluations are crucial for accurate diagnosis.

Effective diagnosis and treatment of comorbid disorders in patients with bipolar enhance care and lead to more optimal mental health outcomes.

Brigitte Robertson, MD, shares information on innovative, genetically targeted treatments for alcohol use disorder, aiming to personalize care and improve patient outcomes.

Newron Pharmaceuticals launches pivotal ENIGMA-TRS trials for evenamide, targeting treatment-resistant schizophrenia with promising efficacy and safety outcomes.

What is the hidden mental health struggles of affluent youth? In this Tales From the Clinic article, we reveal how wealth can contribute to anxiety, depression, and substance misuse.

Discover the unique approaches to treating sleep disorders in children vs adults, highlighting effective behavioral strategies.

May is American Stroke Month. Here, you can find important information about recognizing the signs of the stroke to share with patients.

Combination therapy of TMS and ketamine could enhance brain perfusion and neuroplasticity.